Review Oncologic, Endocrine & Metabolic: Recent developments in matrix metalloproteinase inhibitors
- 1 December 1995
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 5 (12) , 1287-1296
- https://doi.org/10.1517/13543776.5.12.1287
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Inhibition of metalloproteinase by futoenone derivativesBioorganic & Medicinal Chemistry Letters, 1995
- Crystal structures of matrilysin-inhibitor complexesBiochemistry, 1995
- An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase AJournal of Pharmaceutical Sciences, 1995
- Inhibition of Human Stromelysin by Peptides Based on the N-Terminal Domain of Tissue Inhibitor of Metalloproteinases-1Biochemical and Biophysical Research Communications, 1994
- Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitorInternational Journal of Cancer, 1994
- Inhibition of Matrix Metalloproteinases by Peptidyl Hydroxamic AcidsBiochemical and Biophysical Research Communications, 1994
- Matrix Metalloproteinase Inhibitors Containing a [(Carboxyalkyl)amino]zinc Ligand: Modification of the P1 and P2' ResiduesJournal of Medicinal Chemistry, 1994
- Structural implications for the role of the N terminus in the ‘superactivation’ of collagenasesFEBS Letters, 1994
- Synthesis of novel modified dipeptide inhibitors of human collagenase: .beta.-mercapto carboxylic acid derivativesJournal of Medicinal Chemistry, 1993
- Detection of Stromelysin and Collagenase in Synovial Fluid From Patients with Rheumatoid Arthritis and Posttraumatic Knee InjuryArthritis & Rheumatism, 1992